Loading clinical trials...
Loading clinical trials...
Prospective Registry Study of Multimodality Therapy for Oligometastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction
Conditions
Interventions
EORTC QLQ-C30 questionnaire
QLQ-OGS25 questionnaire
Locations
1
United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States
Start Date
August 12, 2024
Primary Completion Date
August 12, 2029
Completion Date
August 12, 2029
Last Updated
May 22, 2025
NCT04674267
NCT07217704
NCT07464470
NCT07132918
NCT07367516
NCT06532006
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions